logo
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates

Yahoo2 days ago

Plus Therapeutics (PSTV) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.75 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -229.41%. A quarter ago, it was expected that this developer of cell therapies would post a loss of $0.51 per share when it actually produced a loss of $0.67, delivering a surprise of -31.37%.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.
Plus , which belongs to the Zacks Medical - Drugs industry, posted revenues of $1.06 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 42.76%. This compares to year-ago revenues of $1.68 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Plus shares have lost about 75.1% since the beginning of the year versus the S&P 500's gain of 0.5%.
While Plus has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Plus: favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.17 on $1.9 million in revenues for the coming quarter and -$0.67 on $8.23 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, IGC Pharma, Inc. (IGC), has yet to report results for the quarter ended March 2025.
This company is expected to post quarterly loss of $0.02 per share in its upcoming report, which represents a year-over-year change of +50%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
IGC Pharma, Inc.'s revenues are expected to be $0.31 million, up 6.9% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Plus Therapeutics, Inc. (PSTV) : Free Stock Analysis Report
IGC Pharma, Inc. (IGC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'This is a roller coaster ride': How Trump's tariffs turned the 'TACO' trade into Wall Street's biggest debate
'This is a roller coaster ride': How Trump's tariffs turned the 'TACO' trade into Wall Street's biggest debate

Yahoo

timean hour ago

  • Yahoo

'This is a roller coaster ride': How Trump's tariffs turned the 'TACO' trade into Wall Street's biggest debate

It was another week of policy pivots, back-and-forth trade headlines, and economic data that did little to anchor investor expectations. In the midst of the chaos, one phrase kept surfacing across Wall Street: the "TACO" trade. An acronym for "Trump Always Chickens Out," it captures a growing belief among investors that the president talks tough on tariffs but rarely follows through. That assumption has fueled a market tailwind in recent months as traders bet on policy pivots, buoyed by an initial US-China tariff deescalation earlier this month. But that narrative hit turbulence this week when Trump lashed out at China in a post on Truth Social, accusing the country of having "violated" its trade deal with the US. While he did not provide specifics, the comments echoed earlier rhetoric from his administration suggesting that negotiations with Beijing had "stalled." Meanwhile, Bloomberg reported that the Trump administration plans to expand tech restrictions on China by targeting subsidiaries of already-sanctioned firms, aiming to close loopholes that allow Beijing to circumvent existing curbs. The news sent stocks sharply lower on Friday. Still, despite those headlines, markets had largely been leaning into the idea that Trump's tough talk rarely translates into tough action. It's a bet that's paid off: Stocks have not only erased their "Liberation Day" losses, but the S&P 500 (^GSPC) secured its best May since 1990 and had the best month since Nov. 2023. But while some on Wall Street still lean into that pattern, others are warning that the trade's logic may have run its course. "We told Donald Trump that we have this 'TACO' trade," Julie Beale, chief market strategist at Kayne Anderson Rudnick, told Yahoo Finance on Thursday, referencing a reporter's question to Trump earlier in the week about the trade. In response, Trump slammed the term, defending his trade stance and brushing off the question as "nasty." "I worry [that] actually makes him bear down a little bit more and decide to be more resilient and more gripping on some of these tariff trades," Beale said. "So I have a little bit of a concern that creates actually more uncertainty." For the most part, this uncertainty has worked in many investors' favor, especially retail traders who have jumped in to "buy the dip" in record numbers, capitalizing on the familiar pattern of policy threats followed by swift deescalation. "They've been able to take advantage of that," Beale said. "A lot of people don't want to be caught out on these big moves upwards." But uncertainty cuts both ways. Rapid policy shifts mean that while markets may continue to chase headlines, the downside risk could become significantly more pronounced if Trump decides to dig in his heels and hold firm on tariffs. "This is a roller coaster ride," S&P Global chief economist Paul Gruenwald said. "Not good for long-term planning and not good for corporate investment." Read more: How to protect your money during turmoil, stock market volatility As investors weigh the fragile state of US-China relations, new questions emerged late Wednesday after a Manhattan-based trade court struck down a wide swath of Trump's tariffs, citing legal issues with how they were implemented. Although a federal appeals court paused that decision on Thursday, temporarily allowing the tariffs to remain in place, the legal back-and-forth has added to market uncertainty. "It's really this overhang of uncertainty that's putting a damper on investment and M&A activity," Gruenwald said. "We're seeing that in the sub-investment grade [credit markets] as well." Callie Cox, chief market strategist at Ritholtz Wealth Management, urged investors to look beyond the tariff drama. "We're going to get a lot of 'he loves me, he loves me not,'" she said, referencing the back-and-forth on policy signals. "What investors really need to be focused on is economic data, especially the jobs report coming up next week, and what the Fed is doing in response to all of this data." Cox noted the Federal Reserve has limited ability to intervene if the economy weakens, adding, "Markets haven't quite processed the fact that the Fed can't step in and help us if the economy does end up weakening." For now, the "TACO" trade remains up for debate. But as the political stakes rise and legal, fiscal, and monetary realities collide, that trade may have less room to run. Allie Canal is a Senior Reporter at Yahoo Finance. Follow her on X @allie_canal, LinkedIn, and email her at Sign in to access your portfolio

2 American Companies That Could Be the Winners of Trump's Tariff Wars
2 American Companies That Could Be the Winners of Trump's Tariff Wars

Yahoo

time2 hours ago

  • Yahoo

2 American Companies That Could Be the Winners of Trump's Tariff Wars

One of the key objectives behind President Trump's tariffs is to bolster domestic manufacturing. While inflation remains a hot-button issue and mortgage rates are still relatively elevated, the home improvement industry could be an under-the-radar opportunity right now. Rising infrastructure spend in the U.S. could help spark demand for domestic steel producers. 10 stocks we like better than Home Depot › It's been almost two months since President Trump's "Liberation Day" announcement, during which he presented a litany of new tariff policies in an effort to level set trade relations which major partners such as China, Europe, and Canada. Since the April 2 announcement, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average have each experienced double-digit declines -- only to rebound sharply over the last few weeks as some updated trade deals have come into view. Even though the market has been roaring as of late, I don't think investors are out of the woods quite yet. Tariff policies can change swiftly, and for now, it's still difficult to discern what companies may come out stronger as a result of these new trade deals. Below, I'll detail how tariffs work and highlight two companies I think could emerge as winners of Trump's tariff wars. Tariffs are a tax that are placed on imported or exported goods. Generally speaking, tariffs are employed as a mechanism to bring other countries to the table and negotiate new terms in trade deals. In addition, tariffs can also be a way to put some pressure on companies to increase domestic manufacturing as opposed to outsourcing labor overseas. While this might sound nice in theory, economists worry that more manufacturing investment in the U.S. will be a costly endeavor for businesses -- hence, they may choose to pass those expenses on to the consumer, thereby spurring inflation. During periods of inflation or high interest rates, consumers may put off investing in home improvement projects or purchasing real estate altogether. While that might give investors some initial feeling of trepidation for Home Depot (NYSE: HD), there's more to the picture. Homeowners know all too well that some projects simply cannot be ignored. Considering the home improvement industry in the U.S. is essentially a duopoly between Home Depot and Lowe's, the company is still positioned to absorb a lot of this demand. Per the graph above, investors can see that over the last two decades, Home Depot has been able to consistently increase revenue and operating margins -- even during times of economic uncertainty. For reference, the two grey-shaded columns represent U.S. recessions. Although there was some pullback in Home Depot's business during these times, the company was ultimately able to outmaneuver these challenges. I see the current tariff situation as no different. Considering Home Depot sources more than half of its inventory from domestic vendors, the company likely will not have to take on as much cost increases from foreign imports compared to smaller competitors or niche retailers. This is important as the majority of the company's goods already come from the U.S. -- making it highly unlikely that it will need to raise prices and stifle consumer purchasing power. The company has made a number of strategic moves to strengthen its supply chain, all while putting the customer first. For this reason, I think Home Depot's business model will hold up resiliently during this period of pronounced tariffs and its stores will remain an essential pocket of the otherwise sensitive retail industry. Next up on my list is steel producer Nucor. In the chart below, investors can see that shares of Nucor have fallen out of favor with investors throughout 2025. While shares have bounced back from lows in April (in parallel with Trump's tariff announcement) the stock is still facing some pressure. For starters, the steel industry is cyclical. This makes expectations around consistent growth somewhat unrealistic. Despite these dynamics, I see Nucor on the precipice of some lucrative opportunities. Higher prices for imported steel from other countries, particularly China, should bode well for Nucor. In addition, since Trump took office in January, a number of companies across many different industry sectors have committed to increased domestic manufacturing. Chief among these initiatives is Project Stargate, a $500 billion vision for more artificial intelligence infrastructure in the U.S. I see these factors as major tailwinds for the steel industry, and I think Nucor is positioned to capture a portion of this spend. For this reason, now could be a good time to buy the dip as Nucor's growth could witness a sharp rebound sooner rather than later. Before you buy stock in Home Depot, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Home Depot wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!* Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Adam Spatacco has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Home Depot. The Motley Fool recommends Lowe's Companies. The Motley Fool has a disclosure policy. 2 American Companies That Could Be the Winners of Trump's Tariff Wars was originally published by The Motley Fool Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

Market Implications Of Tariff Litigation And AI Spending
Market Implications Of Tariff Litigation And AI Spending

Forbes

time2 hours ago

  • Forbes

Market Implications Of Tariff Litigation And AI Spending

Despite what could be a lengthy legal battle, tariffs are unlikely to be removed completely. The ... More sectoral tariffs were not challenged and President Trump added additional steel tariffs on Friday. The tariff dispute does have some crucial implications for future trade deals and the tax bill. US economic data releases, which generally raised estimates of second-quarter economic growth, combined with strong earnings from Nvidia (NVDA), helped send stocks higher for the week. Additionally, improvement in consumer confidence helped raise optimism that the tariff overhang doesn't need to sink the economy. A portion of the tariffs implemented by the Trump administration was briefly overturned, though it was reinstated pending appeal. After the rally last week, the S&P 500 sits only 3.8% below its mid-February high. The Magnificent 7, consisting of Microsoft (MSFT), Meta Platforms (META), (AMZN), Apple (AAPL), NVIDIA (NVDA), Alphabet (GOOGL), and Tesla (TSLA), has fared worse, and the group is 5.5% below its mid-December summit despite outperforming last week. Market Performance The betting odds of a recession in 2025 have continued to decline. This improvement aligns with the supportive economic data released last week, which increased the estimates of US second-quarter GDP growth. Furthermore, the Conference Board's survey of consumer confidence rose after plummeting in the wake of President Trump's tariff announcements on Liberation Day. Betting Odds Of US Recession In 2025 Notably, stocks hit their April low when betting odds of recession were at their highest. As one should expect, the S&P 500 index has risen as the odds of a recession have declined. Stocks & Recession Odds Nvidia did not disappoint investors with better-than-expected quarterly earnings and robust guidance for second-quarter revenue growth of 50% year-over-year. Some worries that the spending on artificial intelligence (AI) infrastructure had weighed on the mega-cap technology companies, as represented by the Magnificent 7. In early April, the group was 30% below their mid-December peak. Most of this decline has reversed due to lower odds of recession. Additionally, the first-quarter earnings season provided evidence of both continued spending on AI infrastructure and, more importantly, proof that companies were successfully monetizing these AI investments into tangible earnings growth. Magnificent 7: Q1 Estimated Earnings Growth Last week, the Court of International Trade (CIT) struck down the majority of the tariffs implemented by the Trump administration. The sectoral tariffs, for example, those on autos and steel, were not impacted by this ruling. The tariffs removed include the 10% universal tariff, the reciprocal tariffs, and the specific tariffs targeting China, Canada, and Mexico. According to Strategas, this would remove about $220 billion in tariffs, leaving just $40 billion of those implemented since the start of the year. Within less than 24 hours after the ruling, the US Court of Appeals for the Federal Circuit granted a stay. Therefore, the tariffs will remain in place, and the US will not yet need to refund the tariff revenue collected to date. This litigation could be a lengthy process, but even if the tariffs are struck down at the end of the litigation, President Trump has the legal authority to reimpose tariffs via alternative methods. However, these methods come with some additional limitations. According to Strategas, Sections 338 and 122 of the Tariff Act of 1930 can be utilized quickly to reinstate many of the tariffs that are currently at risk. Section 338 allows for tariffs of up to 50% that take effect 30 days after announcement, with no time limit on their duration. Section 122 gives the president the authority to impose tariffs of up to 15% with immediate effect, but these tariffs can only remain in place for 150 days without congressional approval. Furthermore, Section 301 of the Trade Act of 1974 permits the imposition of tariffs following an investigation by the United States Trade Representative (USTR). It is doubtful that tariffs will go away unless President Trump decides that they are, but the utilization of other methods is more laborious, time-consuming, and comes with more limitations. Even though tariffs seem likely to remain a part of the investment landscape, regardless of the outcome of the litigation, there are some crucial implications of the additional uncertainty. On the margin, the possibility that the courts could remove the tariffs leaves the Trump administration with less leverage to negotiate trade deals with other countries. Countries may choose to stall and see what happens with the litigation. The G-7 meeting in June could provide some insight into whether any new deals are forthcoming. The tax bill passed by the US House of Representatives was debt-neutral if the revenue from the tariffs was included in the scoring. The risk to the tariff revenue may further complicate the Senate's deliberations in passing a version of the bill. Markets will remain on the tariffs, with markets watching for any changes in US policy and the progress of the legal challenge. Further, retaliation from or trade deals with other countries will be notable. The economic calendar has the critical monthly jobs report on Friday. Expectations are for nonfarm payroll job growth to slow to 125,000 from 177,000 in April. The unemployment rate is expected to remain steady at 4.2%. These forecasts are consistent with the weekly initial filings for unemployment benefits, which remain low and don't indicate a collapse in the labor market. Initial Jobless Claims Ongoing claims for unemployment benefits are rising, indicating that it is taking longer for those losing their jobs to find new employment. The labor market is showing signs of bending but not yet breaking. Continuing Claims Regardless of the outcome of the tariff litigation, tariffs are unlikely to be banished completely. To that point, President Trump imposed a 50% steel tariff late last Friday, and these sectoral tariffs are not part of the current legal challenge. Recent hard economic data, along with some soft data, such as consumer confidence, have raised optimism that US economic growth remains resilient. Furthermore, technology spending related to artificial intelligence continues, with the sector producing robust earnings growth. This week's jobs report will be another key indicator of the US economy's health.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store